CD8A and cancer: Given the specifically inhibitory of role of Tregs in CD8+ T cell cytotoxicity [29], we reasonably hypothesize that the anti-cancer effect of IPG0521m is attributable to its abrogation of Treg-mediated CD8+ T cell suppression.